Dr Alex Zhavoronkov is the CEO and co-founder of Insilico Medicine, the pioneering artificial intelligence company powering innovation in the biopharmaceutical sector. Using next-generation artificial intelligence and deep-learning techniques, Insilico Medicine identifies novel molecular structures with unique properties for drug discovery programmes in different disease areas, as well as for crucial Longevity research.